Small-cell lung cancer (SCLC) is a highly aggressive disease that exhibits rapid growth and genetic instability. We found earlier frequent overexpression of the miR-17-92 microRNA cluster, and showed that SCLC cells were addicted to continued expressions of miR-17-5p and miR-20a, major components of this microRNA cluster. In this study, we identified the frequent presence of constitutively phosphorylated H2AX (c-H2AX), which reflects continuing DNA damage, preferentially in SCLC. Knockdown of RB induced c-H2AX foci formation in non-small cell lung cancer (NSCLC) cells with wild-type RB, in association with growth inhibition and reactive oxygen species (ROS) generation, which was canceled by overexpression of miR-17-92. Conversely, induction of c-H2AX was observed in a miR-17-92-overexpressing SCLC cell line with miR-20a antisense oligonucleotides. These findings suggest that miR-17-92 overexpression may serve as a fine-tuning influence to counterbalance the generation of DNA damage in RB-inactivated SCLC cells, thus reducing excessive DNA damage to a tolerable level and consequently leading to genetic instability. Therefore, miR-17-92 may be an excellent therapeutic target candidate to elicit excessive DNA damage in combination with DNA-damaging chemotherapeutics.
Introduction
Small-cell lung cancer (SCLC), which constitutes about 13% of newly diagnosed lung cancers, is highly aggressive, with a rapid doubling time and early metastatic behavior. The majority of patients have advanced disease and long-term survival remains disappointing, with a 2-year survival rate lower than 5% in those with extensive disease. Earlier studies have provided clear evidence of multi-step accumulations of genetic and epigenetic alterations in both tumor suppressor genes and dominant oncogenes, as well as highly frequent chromosomal aberrations. The RB and p53 genes, which are altered in nearly 90% of SCLCs, are among the most prevalent targets for such alterations, suggesting their crucial roles in pathogenesis.
Abrogation of highly conserved DNA damage response pathways, which allow cells to respond to both endogenous and exogenous sources of DNA damage, may contribute to the induction of chromosomal and genetic instabilities. Along this line, we reported earlier that those pathways in various phases are frequently impaired in SCLCs (Konishi et al., 2002; Nakagawa et al., 2004; Ebi et al., 2007) , suggesting their involvement in carcinogenesis. In addition to conventional protein-coding genes, recent studies including our own strongly suggest that microRNAs (miRNAs), which negatively regulate the expression of target genes with coding capacity, play important roles in lung carcinogenesis and disease progression (Takamizawa et al., 2004; Hayashita et al., 2005; Johnson et al., 2005; Matsubara et al., 2007; Taguchi et al., 2008; Tokumaru et al., 2008) . We earlier discovered frequent overexpression and occasional gene amplification of miR-17-92 in SCLCs (Hayashita et al., 2005; Matsubara et al., 2007) , whereas SCLC cells were also shown to be addicted to continued expressions of miR-17-5p and miR-20a, major components of this miRNA cluster (Hayashita et al., 2005; Matsubara et al., 2007; Taguchi et al., 2008) . It is interesting that close relationships of miR-17-92 with normal lung development and proliferation have been reported in gene-engineered mice. Overexpression of this cluster in embryonic lung epithelium induced epithelial cell proliferation, especially in neuroendocrine cell clusters (Lu et al., 2007; Ventura et al., 2008) , whereas mice deficient of miR-17-92 died shortly after birth with lung hypoplasia (Lu et al., 2007; Ventura et al., 2008) . However, it remains to be elucidated how overexpression of miR-17-92 contributes to lung cancer development, especially in cases with an SCLC histology.
In this study, we found frequent constitutive occurrence of phosphorylated H2AX (g-H2AX) induction, which reflects continuing DNA damage, preferentially in SCLC. We also show that RB inactivation induces g-H2AX foci formation, growth inhibition and reactive oxygen species (ROS) generation, which were canceled by overexpression of miR-17-92, suggesting a counterbalancing role for miR-17-92 overexpression in the pathogenesis of SCLC.
Results
Constitutive H2AX phosphorylation in SCLC cell lines Our earlier observations of constitutive foci of phosphorylated ATM and g-H2AX in an SCLC cell line, ACC-LC-80, in the absence of exogenous DNA-damaging insult prompted us to examine a panel of lung cancer cell lines, including five SCLC and five non-small cell lung cancer (NSCLC) cell lines. In this study, the SCLC cell lines generally exhibited constitutive g-H2AX foci at higher frequencies than the NSCLC cell lines (Figures 1a and b) . The presence of constitutive g-H2AX foci was associated with inactivation of both RB and p53 in all SCLC cells, and p53 mutations in NSCLC cells. Interestingly, western blot analysis showed a distinct persistence of irradiationinduced H2AX phosphorylation, even at 10 h after 4 Gy of irradiation, in ACC-LC-48 and ACC-LC-76 SCLC cell lines with constitutive g-H2AX foci (Figure 1c) . In contrast, a return to the non-induced negligible phosphorylation level was observed in A549, NCI-H460 and A427 NSCLC cell lines. These findings raised the possibility that SCLC cells suffered from insufficient dephosphorylation of g-H2AX, caused by protein phosphatase 2A (PP2A) (Chowdhury et al., 2005) . Indeed, inhibition of PP2A expression by small interfering RNA (siRNA) treatment in A549 NSCLC cells resulted in elevated constitutive phosphorylation of H2AX, which also tended to remain in the activated state after irradiation (Supplementary Figure 1) . In addition, we used an immunohistochemical method to examine 18 primary SCLC tissue specimens, among which discrete g-H2AX foci formation was observed in 11 cases with varying expression levels ( Figure 1d ).
Search for mutations in the H2AX and PP2A genes in SCLC cell lines Mutations of the H2AX gene were first sought as possible causes for the observed constitutive activation. However, RT-PCR-direct sequence analysis failed to identify any mutations in the panel nine SCLC and five NSCLC cell lines. Next, we searched for mutations in the regulatory A (PPP2R1A and 1B) and catalytic C (PPP2CA) subunits of PP2A in eight SCLC cell lines, as both isoforms of the A subunit were reported to be mutated in lung cancers (Wang et al., 1998) , and the catalytic subunit was earlier shown to co-immunoprecipitate and colocalize with g-H2AX in DNA damage foci (Chowdhury et al., 2005) . Direct sequencing of the PCR amplification products showed three missense changes in PPP2R1B in three of the eight SCLC cell lines, including a G408R mutation in ACC-LC-48, I342M in ACC-LC-76 and L105F in SK-LC-2 ( Supplementary  Figure 2) , suggesting that additional mechanisms are also involved in constitutive g-H2AX foci formation.
Relationships of increased ROS and g-H2AX foci with RB inactivation in SCLC cell lines Even without exogenous stress such as irradiation, DNA is exposed to endogenous sources of damage such as ROS. Therefore, constitutive intracellular ROS levels were examined by counting the number of carboxy-2 0 ,7 0 -dichlorodihydrofluorescein (carboxy-H 2 DCFDA)-stained cells (Figure 2a ), as well as by flow cytometric analysis of H 2 DCFDA staining intensity (Supplementary Figure 3) . Those results showed generally higher intracellular levels of ROS in the SCLC cell lines. A549 cells exhibited g-H2AX foci formation in response to treatment with tert-butyl hydroperoxide, which generates ROS (Supplementary Figure 4) , whereas treatment with N-acetylcysteine, an ROS inhibitor, showed moderately decreased g-H2AX foci in two of the three SCLC cell lines examined, suggesting that the constitutive presence of ROS may have a role, although limited, in the constitutive formation of g-H2AX foci in a fraction of SCLC cell lines (Figure 2b ). RB and/or p53 mutations, which are known to be characteristically prevalent in SCLCs, were shown to be associated with the presence of constitutive g-H2AX foci in the present panel of cell lines ( Figure 1a ). We also observed that siRNA-mediated RB inactivation in A549 cells carrying wild-type RB and p53, as well as in Calu-1 cells carrying wild-type RB and homozygous deletion of p53, resulted in increased g-H2AX foci formation ( Figure 3a , data not shown for Calu-1), along with increased g-H2AX expression levels ( Figure 3b ). In addition, we found that siRNA-mediated inhibition of RB modestly elevated the intracellular levels of ROS in A549 cells as well as in Calu-1 cells (Figure 3c ), and that reduction of ROS generation by treatment with Nacetylcysteine modestly reduced the number of g-H2AX foci in A549 cells treated with si-RB (Po0.01, Figure 3d ). Inhibition of p53 expression had no effects on ROS generation in A549 cells (Figure 3c ).
Counterbalancing roles of miR-17-92 overexpression and cyclin E knockdown in effects mediated by RB In addition to RB knockdown-induced generation of ROS and g-H2AX foci formation, we observed growth inhibition and increased apoptosis in si-RB-treated A549 cells (Figure 4a and Supplementary Figure 5) . We earlier found that antisense oligonucleotides against miR-17-5p and miR-20a, major components of the miR-17-92 cluster, induced apoptosis in SCLCs overexpressing miR-17-92 (Matsubara et al., 2007) . In this miRNA, ROS and DNA damage in lung cancer H Ebi et al study, we investigated whether miR-17-92 overexpression alleviates the adverse effects of RB knockdown. Although siRNA-mediated RB inactivation resulted in a significant reduction of cell growth (Po0.05, Figure 4a ), which was associated with induction of apoptosis in A549 cells (Supplementary Figure 5) , co-transfection of et al., 2005) , which was accompanied by a reduction in cyclin E expression that was markedly upregulated in response to RB silencing. Overexpression of miR-20a also induced downregulation of the cyclin-dependent kinase inhibitor p21 and pro-apoptotic protein Bim, Figure 7) . We also noted that co-transfection of miR-20a alleviated ROS generation, which was modestly increased in si-RB-transected A549 cells (Figure 4c ). Having observed that miR-20a overexpression clearly reduced markedly elevated cyclin E levels caused by E2F1 activation after si-RB treatment, we also investigated whether the counterbalancing effects of miR-20a overexpression could be mimicked by cyclin E inhibition.
Indeed, knockdown of cyclin E resulted in a significant decrease in g-H2AX upregulation and also rescued cell growth inhibition, although to a lesser extent than with miR-20a overexpression, in A549 cells treated with si-RB (Figures 4d and e) . These findings suggest that the E2F1-cyclin E axis may be a major downstream effecter of miR20a overexpression, although additional mechanisms might also be involved.
Overexpression of miR-20a may interfere with the processing and expression of other types of miRNA. However, this possibility is unlikely with the present miRNA, ROS and DNA damage in lung cancer H Ebi et al experimental conditions, because real-time TaqMan RT-PCR analysis showed that miR-20a overexpression did not significantly affect the expression levels of multiple miRNAs (Supplementary Figure 8) . Next, we examined ACC-LC-48 and ACC-LC-172 SCLC cells, both of which carry RB inactivation and overexpression of miR-17-92, for the induction of g-H2AX in response to inhibition of endogenously overexpressed miR-20a. As shown in Figure 5a , transfection of antisense locked nucleic acid oligonucleotide abrogated the expression of mature miR-20a in ACC-LC-172 and ACC-LC-48 cells, which resulted in the induction of g-H2AX, E2F1 and cyclin E, along with other molecules, including cleaved caspase 7, p21, and, to a lesser extent, Bim (Figure 5b ).
Discussion
The DNA replication stress, such as untimely DNA synthesis and replication fork collapse with subsequent formation of DSBs, is one of the mechanistic bases for eliciting DNA damage in cancer cells. DNA damage and consequential activation of DNA damage response are crucially involved in the processes of tumor initiation and progression (Halazonetis et al., 2008) . Among the various types of lung cancer, SCLC cells are known to frequently carry aberrations of multiple genes and chromosomes (Sekido et al., 2003) . In this study, we identified the constitutive occurrence of g-H2AX foci formation, a reflection of DNA damage response, in the majority of tested SCLC cell lines. Our extensive search miRNA, ROS and DNA damage in lung cancer H Ebi et al did not find mutations in the H2AX gene and PPP2R1B (A b-subunit) mutations do not seem to fully explain the highly frequent constitutive g-H2AX foci formation seen in SCLC cells. These results suggest that RB inactivation, highly characteristic of SCLC, may play a role in the constitutive induction of g-H2AX foci in SCLC, which seems to be consistent with earlier reports on the relationship between RB inactivation and accumulation of DNA double-strand breaks in other cell types (Pickering and Kowalik, 2006; Tort et al., 2006) . It would be interesting to investigate which genetic and/or epigenetic aberrations in NSCLC are the major causative factors involved in the induction of g-H2AX in a fraction of NSCLC specimens (Bartkova et al., 2005; Gorgoulis et al., 2005; Nuciforo et al., 2007) . In contrast to RB, p53 inactivation did not seem to be causally involved in the constitutive induction of g-H2AX in lung cancer cells, although p53 mutations showed associations with constitutive g-H2AX foci formation in both SCLC and NSCLC cell lines, which is consistent with the notion that DNA damage response impairment imposed by tumor suppressor alterations such as p53 mutations may be a critical step to evade safeguards against tumor progression (DiTullio et al., 2002; Bartkova et al., 2005; Gorgoulis et al., 2005) . Our results also indicate that SCLC cells constitutively exhibit frequent elevation of ROS, which has been suggested to play roles in cancer development by causing DNA damage, whereas two of the three SCLC cell lines examined exhibited partially reduced g-H2AX foci after treatment with N-acetylcysteine, an ROS inhibitor. Although the underlying mechanism of ROS accumulation in SCLC remains to be further elucidated, we observed a modest increase in ROS generation by siRNA-mediated RB inactivation. Along this line, it has also been reported that increased expression of E2F1 generated ROS in osteosarcoma and mouse NIH3T3 cells (Tanaka et al., 2002) . However, there are conflicting reports that described a lack of ROS induction in normal human fibroblasts overexpressing exogenous E2F1 (Powers et al., 2004; Pickering and Kowalik, 2006) , suggesting that this effect may depend on cell type and genetic background.
Our findings also highlight a potential role for miR-17-92 in the process of DNA damage and ROS accumulation in SCLC. We earlier identified preferential overexpression of miR-17-92 in SCLC cells (Hayashita et al., 2005) , along with significant induction of apoptosis by inhibition of miR-17-5p and miR-20a, major components of miR-17-92 (Matsubara et al., 2007) . However, those results did not clarify how overexpression of this miRNA cluster contributes to the development of SCLC. This findings suggest that even though additional mechanisms may be involved, overexpression of miR-17-92 contributes to the survival of SCLC cells by reducing DNA damage in those cells carrying RB inactivation by attenuation of RB inactivation-mediated upregulation of cyclin E, a downstream transcriptional target of E2F1 that is a direct target of miR-20a (O'Donnell et al., 2005) . E2F1 is an oncogenic molecule per se that leads to deregulated cell proliferation and predisposes cells to transformation, whereas it is also known to mediate both p53-dependent and independent apoptotic signals when they occur over a critical threshold (Putzer, 2007) . It is possible that overexpression of miR-20a has a counterbalancing role, consequently reducing constitutive DNA damage to a beneficial level for the development of SCLC. Finally, it is interesting that after submission of this paper, Pickering et al. (2009) reported the importance of miR-17-5p/20a-mediated accurate control of E2F1 for dictating S-phase entry without causing DNA doublestrand breaks or g-H2AX foci formation.
In conclusion, these results suggest that miR-17-92 may contribute to protect SCLC cells carrying RB inactivation from excessive DNA damage and paradoxical growth inhibitory effects, to a large extent by direct downregulation of E2F1 expression. Our findings also shed light on the roles of miR-17-92 overexpression in fine-tuning ROS generation. These findings suggest that survival of SCLC cells with overexpression of miR-17-92 may rely on a finely tuned, intricate balance mediated by this miRNA cluster. A future study may show that miR-17-92 is an excellent therapeutic target candidate to elicit excessive DNA damage in combination with DNA-damaging chemotherapeutic agents to kill cancer cells.
Materials and methods

Cell lines and clinical specimens
Derivations and characteristics of the tested cell lines have been reported earlier (Hayashita et al., 2005; Ebi et al., 2007) . Formalin-fixed, paraffin-embedded specimens were immunohistochemically analysed using a standard avidin-biotinperoxidase complex method after antigen retrieval with a microwave procedure. The 14 human lung cancer cell lines analysed for the H2AX mutation were A549, Calu-1, NCI-H460, ACC-LC-176, PC-10 (NSCLC) and . The eight SCLC cell lines analysed for the PP2A mutation were ACC- and SK-LC-2. Sequences of the PCR primers used in this study are provided in Supplementary Table 1 .
Antibodies and intracellular ROS detection
Antibodies used in this study were the catalytic subunit of PP2A, H2AX and g-H2AX (Upstate Biotechnology, Lake Placid, NY, USA); RB and p21 (BD Bioscience, San Diego, CA, USA); E2F1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); cleaved caspase 7 and Bim (Cell Signaling Technology, Danvers, MA, USA) and cyclin E (Novocastra, Newcastle, UK). Immunofluorescence analysis and western blot analysis were done as described earlier . To quantify the frequency of cells with constitutive g-H2AX foci, we counted at least 200 cells in each assay, in which cells were scored as positive when more than three foci per cell were observed. To detect ROS by flow cytometry or fluorescence microscopy, we used carboxy-H 2 DCFDA (Molecular Probes, Eugene, OR, USA), according to the manufacturer's instructions.
Oligonucleotides and transfection experiments
Cells were transfected with 10 nmol/l of the pre-miR miRNA precursor molecule of miR-20a, negative control (both from Applied Biosystems, Foster City, CA, USA), 50 nmol/l of a siRNA duplex (Dharmacon, Lafayette, CA, USA) targeting PPP2CA, 50 nmol/l of a siRNA duplex (SigmaAldrich, St Louis, MO, USA) targeting RB, p53, cyclin E, or the scramble siRNA (Invitrogen, Carlsbad, CA, USA) using Lipofectamine RNAiMAX (Invitrogen). ACC-LC-172 and ACC-LC-48 cells were transfected with 20 nmol/l of locked nucleic acid antisense oligonucleotides (Greiner, Tokyo, Japan) against miR-20a/scramble using Lipofectamine 2000 (Invitrogen). A549 cells were transfected with 50 nmol/l of si-RB or the negative control in the presence of the pre-miR miRNA precursor molecule of miR-20a or negative control. The transfection experiments and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were performed as described earlier (Matsubara et al., 2007) . Northern blot analysis of miRNA expression was performed as described earlier (Hayashita et al., 2005) . Sequences of the oligonucleotides used in this study are summarized in Supplementary Table 2 .
Statistical analysis
Comparisons between groups were made using a two-sided Welch's t-test.
